Clinical Trial Update: Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Indium-111 labeled panitumumab for nodal staging in head and neck cancer is currently suspended; no results are reported in this update…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 111In-Panitumumab (panitumumab (Indium-111 radiolabeled))

Snippet

Sponsor: Stanford University | Conditions: Head and Neck Cancer | Phase 1 | Status: SUSPENDED